Skip to main content
. 2019 Dec;73(6):425–432. doi: 10.5455/medarh.2019.73.425-432

Table 4. Adverse neonatal outcomes among our sample.. CI = Confidence Interval. Odds Ratio was calculated for obesity in general against adverse pregnancy outcomes. *These data were taking from Haseeb et. al study for comparison between obese and non-obese. aP<.05, bP<.001.

Neonatal Outcomes Normal BMI* Obese class I Obese class II Obese class III Odds ratio (CI) Frequency
N = 729 (18.5-24.9) (30-34.9) (35-39.9) (>40.0)
N=300 N=620 N=262 N=155
NICU admissiona - 57 (9.19%) 11 (4.19%) 0 1.01(0.95-1.06) 68
Birth Injury - 3 (0.48%) 1 (0.83%) 0 0.75(0.1-7.24) 4
Birth defect - 18 (2.90%) 1 (0.83%) 1(0.65%) 1.01(0.92-1.12) 21
Cardiac anomaly - 1 (0.16%) 3 (1.14%) 0 0.7(0.2-2.4) 4
Clift lip and palate - 1 (0.16%) 1 (0.83%) 0 1.1(0.16-7.51) 2
Anencephaly - 4 (0.64%) 0 0 - 4
Spina bifidaa - 1 (0.16%) 1 (0.83%) 0 1.14(0.15-9.01) 2
Hydrocephalus - 4 (0.64%) 0 0 - 4
Ambiguous genetalia - 1 (0.16%) 0 0 - 1
IUFDa - 6 (0.96%) 2 (0.76%) 0 0.94(0.83-1.07) 8
Neonatal deatha - 7 (1.12%) 1 (0.83%) 0 1.01(0.86-1.17) 8
Low APGAR at 1 minb - 68 (10.96%) 33 (12.59%) 23 (15.33%) 0.99(0.95-1.03) 124
Low APGAR at 5 minb - 60 (9.67 %) 25 (9.54%) 14 (9.33%) 1(0.96-1.05) 99
Low birthweightb - 70 (11.29%) 26 (9.92%) 15 (10%) 1(0.67-1.95) 111
Macrosomiab 45 (15%) 75 (12.09%) 24 (9.16%) 18 (12%) 1(0.63-1.49) 117
Preterm birthb 21 (7.1%) 74 (11.9%) 31 (11.83) 19 (12.66%) 1(0.5-1.7) 124
Posttermb - 21 (3.38%) 3 (1.14%) 4 (2.66%) 1.3(0.22-1.81) 28